End diastolic diameter
1 paper1 finding
Interventions
1Cardiac xenotransplantation
downin humans1
1 study
Cardiac xenotransplantation
downin humans1
Cardiac xenotransplantation decreases end diastolic diameter in humans (-40.2% (CI 20.3-64.1%)).
“From post-operative day (POD) 1 of xenotransplant to end-of-life, RVWT increased 80.9% (CI 95.6-118.5%) while EDD decreased 40.2% (CI 20.3-64.1%).”
Human trialin cardiac xenotransplant recipientsheartn = 2
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
4 in 12 monthsESC Heart Failure
Dapagliflozin effects on right ventricular function, pulmonary pressure and coupling: a propensity score analysis from the RIVED-HF
Cohort study of 142 peopleDapagliflozin
Frontiers in Pharmacology
Metabolic remodeling and cardiac functional adaptation mediated by dapagliflozin in patients with acute heart failure: a retrospective cohort study
Cohort study of 50 peopleDapagliflozin
Research Square
Prognostic Association and Predictive Value of the Stress Hyperglycemia Ratio for All‑Cause Mortality in Elderly Hip Fracture Patients with Perioperative Atrial Fibrillation
Preprint: cohort study of 340 peopleHip fracture
American Journal of Cardiovascular Drugs
Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial
Trial in peopleInterventions
World Journal of Diabetes
Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety
Cohort study of 102 peopleDapagliflozin